ZZPZH(SH:600436) Zheng Quan Shi Bao Wang·2025-09-28 11:40Core Viewpoint - The company, Pianzaihuang, is actively seeking new growth opportunities by investing in the Zhongjin Medical Fund, which aligns with its strategy to enhance industrial synergy and competitive capabilities in the health industry [2][4]. Group 1: Investment Details - Pianzaihuang plans to invest 200 million yuan in the Zhongjin Medical Fund, which has a target fundraising scale of 1 billion yuan, making the company's contribution 20% of the total [2]. - The investment has been approved by the company's board and supervisory board, and the fund is currently in the preparatory stage [2]. - The fund is managed by Zhongjin Capital, a leading private equity investment management platform in China [2]. Group 2: Strategic Context - The Zhongjin Medical Fund is part of the "Yuanshan Plan" initiated by Zhangzhou City to promote the integration of medical, healthcare, and tourism industries, with a total planned scale of 5 billion yuan for the industry fund [3]. - Pianzaihuang has previously invested in three other funds under the "Yuanshan Plan," each with an investment of 200 million yuan and a 20% share [3]. - The fund will focus on the healthcare sector, including traditional Chinese medicine, biomedicine, medical devices, and related industries, which may include projects within Pianzaihuang's industrial chain [3]. Group 3: Company Strategy - Pianzaihuang is enhancing its pharmaceutical operations and related investments, leveraging its brand value and resources in the biopharmaceutical supply chain [4]. - The company aims to strengthen its core competitiveness in the traditional Chinese medicine sector and solidify its leading position through strategic investments and acquisitions [4].